Adult cancer pain.

Robert Swarm, MD; Amy Pickar Abernethy, MD; Doralina L. Anghelescu, MD; Costantino Benedetti, MD; Craig D. Blinderman, MD, MA; Barry Boston, MD; Charles Cleeland, PhD; Nessa Coyle, PhD, NP; Oscar A. deLeon-Casasola, MD; June G. Eilers, PhD, APRN; Betty Ferrell, RN, PhD; Nora A. Janjan, MD, MPSA, MBA; Sloan Beth Karver, MD; Michael H. Levy, MD, PhD; Maureen Lynch, MS, APRN; Natalie Moryl, MD; Barbara A. Murphy, MD; Suzanne A. Nesbit, PharmD, BCPS; Linda Oakes, RN, MSN; Eugenie A. Obbens, MD, PhD; Judith A. Paice, PhD, RN; Michael W. Rabow, MD; Karen L. Syrjala, PhD; Susan Urba, MD; and Sharon M. Weinstein, MD

[1]  N. Slatkin.  Opioid switching and rotation in primary care: implementation and clinical utility , 2009, Current medical research and opinion.

[2]  Nijmeh Al-Atiyyat.  Cultural Diversity and Cancer Pain , 2009 .

[3]  M. Levy,et al.  Management of Chronic Pain in Cancer Survivors , 2008, Cancer journal.

[4]  P. Hawley,et al.  A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. , 2008, Journal of palliative medicine.

[5]  C. Tamasdan,et al.  Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia. , 2007, Journal of opioid management.

[6]  F. Fulfaro,et al.  A Prospective Randomized Study of Corticosteroids as Adjuvant Drugs to Opioids in Advanced Cancer Patients , 2007, The American journal of hospice & palliative care.

[7]  R. Barkin,et al.  Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. , 2006, American journal of therapeutics.

[8]  R. Serlin,et al.  Racial and ethnic disparities in pain management in the United States. , 2006, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[9]  E. Prommer.  Modafinil: is it ready for prime time? , 2006, Journal of opioid management.

[10]  M. Kris,et al.  Analgesic effect of gefitinib in the treatment of non-small cell lung cancer. , 2006, The journal of supportive oncology.

[11]  S. Mercadante,et al.  Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. , 2005, Journal of pain and symptom management.

[12]  Linqiu Zhou,et al.  Pharmacologic Management of Cancer Pain , 2005, The Journal of the American Osteopathic Association.

[13]  W. Breitbart,et al.  Atypical antipsychotics in the management of delirium: A review of the empirical literature , 2005, Palliative and Supportive Care.

[14]  Amy M Rybarczyk,et al.  Pharmacologic Treatment of Opioid-Induced Sedation in Chronic Pain , 2005, The Annals of pharmacotherapy.

[15]  E. Kalso,et al.  Breakthrough pain in malignant and non‐malignant diseases: a review of prevalence, characteristics and mechanisms , 2005, European journal of pain.

[16]  P. Jacobsen,et al.  A Double-Blind Trial of Haloperidol, Chlorpromazine, and Lorazepam in the Treatment of Delirium in Hospitalized AIDS Patients , 2005 .

[17]  David A. Flockhart,et al.  CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. , 2005, Journal of the National Cancer Institute.

[18]  H. Chen,et al.  Contemporary management of neuropathic pain for the primary care physician. , 2004, Mayo Clinic proceedings.

[19]  D. Weissman,et al.  Neuroexcitatory effects of opioids: patient assessment #57. , 2004, Journal of palliative medicine.

[20]  R. Portenoy,et al.  Adjuvant analgesics in cancer pain management. , 2004, The oncologist.

[21]  M. Stockler,et al.  Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  G. Gonzales,et al.  Neuropathic Pain in Patients with Cancer , 2003, Journal of palliative care.

[23]  Marlene Z. Cohen,et al.  Cancer pain management and the JCAHO's pain standards: an institutional challenge. , 2003, Journal of pain and symptom management.

[24]  J. Lau,et al.  Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. , 2003, The journal of pain : official journal of the American Pain Society.

[25]  M. Rajagopal,et al.  Intravenous morphine for rapid control of severe cancer pain , 2003, Palliative medicine.

[26]  Mellar P. Davis,et al.  Opioids in cancer pain: common dosing errors. , 2003, Oncology.

[27]  L. Primavera,et al.  A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl , 2001, Cancer.

[28]  A. Caraceni,et al.  Classification of cancer pain syndromes. , 2001, Oncology.

[29]  D. Hewitt.  The management of pain in the oncology patient. , 2001, Obstetrics and gynecology clinics of North America.

[30]  C. L. Hicks,et al.  The Faces Pain Scale – Revised: toward a common metric in pediatric pain measurement , 2001, Pain.

[31]  Mellar P. Davis,et al.  The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine , 2001, Supportive Care in Cancer.

[32]  E. Kalso,et al.  Morphine and alternative opioids in cancer pain: the EAPC recommendations , 2001, British Journal of Cancer.

[33]  S. Kaasa,et al.  Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. , 2000, Acta anaesthesiologica Scandinavica.

[34]  E. Bruera,et al.  A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. , 2000, Journal of pain and symptom management.

[35]  R. Stevens,et al.  Routes of opioid analgesic therapy in the management of cancer pain. , 2000, Cancer Control: Journal of the Moffitt Cancer Cente.

[36]  T. Pellino,et al.  Assessment of the validity and reliability of the University of Wisconsin Children's Hospital Pain scale for Preverbal and Nonverbal Children. , 1999, Pediatric nursing.

[37]  S. Mercadante.  Pathophysiology and treatment of opioid-related myoclonus in cancer patients , 1998, Pain.

[38]  M. Marinella.  Acute colonic pseudo-obstruction complicated by cecal perforation in a patient with Parkinson's disease. , 1997, Southern medical journal.

[39]  N. Hagen,et al.  Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. , 1997, Journal of pain and symptom management.

[40]  E. Zecca,et al.  An update on the clinical use of methadone for cancer pain , 1997, Pain.

[41]  S. Mercadante.  Malignant bone pain: pathophysiology and treatment , 1996, Pain.

[42]  J. Stjernswärd,et al.  The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. , 1996, Journal of pain and symptom management.

[43]  Katherine R. Edwards,et al.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function , 1995, Pain.

[44]  H. Thaler,et al.  Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients , 1995, Pain.

[45]  H. Merskey,et al.  Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. , 1994, Pain. Supplement.

[46]  C. Cleeland,et al.  Pain and its treatment in outpatients with metastatic cancer. , 1994, The New England journal of medicine.

[47]  R. Portenoy,et al.  Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure , 1991, Pain.

[48]  R. Portenoy,et al.  Cancer pain. Epidemiology and syndromes , 1989, Cancer.

[49]  W. Ensminger,et al.  Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. , 1982, Journal of neurosurgery.

[50]  H. Putter,et al.  Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: A pharmacoepidemiologic study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  D. Turk,et al.  Dextropropoxyphene: safety and efficacy in older patients. , 2005, Drugs & aging.

[52]  Karen Albert.  Journal of the National Comprehensive Cancer Network (JNCCN) , 2005 .

[53]  S. Kaasa,et al.  Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine , 2000, European Journal of Clinical Pharmacology.

[54]  P. Boyle,et al.  Pathophysiology and Treatment , 2000 .

[55]  D. Walsh,et al.  Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride. , 1999, Journal of pain and symptom management.

[56]  S. Mercadante.  Comments on Wang et al., PAIN, 67 (1996) 407-416. , 1998, Pain.

[57]  M. McCarron,et al.  Pentazocine (Talwin) intoxication: report of 57 cases. , 1990, The Journal of emergency medicine.

[58]  J. Stjernswärd.  WHO cancer pain relief programme. , 1988, Cancer surveys.

[59]  B. Chir.,et al.  Cancer pain. , 1987, The Medical clinics of North America.

[60]  J. Bonica,et al.  Management of cancer pain. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.